AI-generated summary
The authors report a prospective cohort study of 95 patients with symptomatic varicose veins, allocated non-randomly to four treatment groups. Endovenous laser ablation with a 1470-nm laser was associated with lower serum levels of several inflammation and remodeling markers and better quality-of-life scores, with the best results when combined with MPFF. The non-random allocation limits the strength of these associations.
- Participants
- 95
- Who or what was studied
- Patients with symptomatic varicose veins and chronic venous disease, clinical class C2-C3 (CEAP classification), N = 95
- Wavelengths
- 1470 nm
- Limits stated in the abstract
- Non-random allocation into four groups in a prospective cohort design, so group differences may reflect confounding rather than treatment effects.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1470 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Inflammation, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.